<DOC>
	<DOCNO>NCT01404845</DOCNO>
	<brief_summary>•Purpose : Age-related Macular Degeneration ( AMD ) lead cause blindness visual impairment industrialized country . The macular pigment , compose carotenoid derivative ( lutein zeaxanthin ) , may play important role occurrence AMD . An increase macular pigment follow dietary supplementation lutein zeaxanthin could allow early treatment supplement subject high risk AMD , encourage change eat habit . •Primary outcome : Comparative analysis density evolution density macular pigment : - In patient without retinal pathology underwent cataract surgery 1 month previously - In non-exudative eye patient exudative AMD one eye analyze density evolution density macular pigment non-exudative eye - Secondary outcome : Analysis change macular pigment density take food supplement ( Nutrof Total versus comparator ) : - Time take reach maximum plateau macular pigment density ( increase density 2 measurement ) - Time take return baseline macular pigment density cessation supplementation - Study design : Pilot study -Prospective , randomised , double-masked , comparative , multicenter .</brief_summary>
	<brief_title>Macular Pigment Density Evolution Unilateral Wet AMD Versus Non AMD Patients With Without Lutein Zeaxanthine Supplementation</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Wet Macular Degeneration</mesh_term>
	<criteria>Inclusion criterion : Both gender ( male female ) , ≥ 55 year age . Patients without retinal pathology underwent cataract surgery 1 month previously Or Patients neovascular AMD ( Agerelated macular Degeneration ) one eye . Patients give write consent Exclusion criterion relate study : Intolerance test product Change fundus image Patients already take Nutrof Total similar supplement contain Lutein Zeaxanthin Allergy mydriatic Exclusion criterion ophthalmologic reason : Ocular disease condition whose presence might interfere measurement optical density macular pigment ( e.g . cataract , diabetic retinopathy , optic atrophy , myopia &gt; 6.5 Diopters ) Exclusion criterion systemic reason : Medical surgical history , disorder disease ( e.g . severe organic disease , acute chronic : liver disease , endocrine , neoplastic , hematologic , infectious disease , severe psychiatric disorder , significant cardiovascular abnormality , etc ... ) / aggravate factor structural defect , consider inconsistent study investigator . Exclusion criteria general reason : Inability patient understand study procedure give inform consent . Ward court Patient cover social security scheme Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>exudative AMD</keyword>
	<keyword>dietary supplement</keyword>
	<keyword>macular pigment</keyword>
	<keyword>lutein</keyword>
	<keyword>zeaxanthin</keyword>
	<keyword>Nutrof total</keyword>
	<keyword>one eye</keyword>
</DOC>